If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

Share Price is delayed by 15 minutes
Get Live Data
34.15    -0.20 (-0.58%)
Bid:
34.15
Ask:
34.45
Spread: 0.30 (0.878%)
Market Cap: £100.84m
SFR Live PriceLast checked at - London Stock Exchange

Intraday Severfield Share Chart

Director/PDMR Shareholding

31 Jul 2023 15:18

RNS Number : 7774H
Severfield PLC
31 July 2023
 

Date of notification: 28th July 2023

SEVERFIELD PLC

DIRECTOR/PDMR SHAREHOLDINGS-AWARD OF DEFERRED BONUS SHARES

Severfield plc ("the Company") wishes to notify the following changes in the interests of persons discharging managerial responsibility ("PDMRs") in ordinary shares ("Shares").

GRANT OF DEFERRED BONUS SHARE AWARDS

On 28th July 2023 a grant of the following deferred awards over Shares under the Company's Deferred Share Bonus Plan ("DSBP") was made to the following PDMRs representing a proportion of their bonus entitlement for the financial year to 31 March 2023:

Name of PDMR

No. of shares held under the award

Alan Dunsmore (CEO)

211,416

Ian Cochrane (COO)

188,253

Adam Semple (Finance director)

144,484

Derek Randall (Director)

156,893

 

The awards are structured as nil exercise cost options normally exercisable between 3 and 10 years after grant. No consideration was paid for the grant of the awards. 

The Company was notified of these transactions on 28th June 2023.

Details of the full notifications received by the Company are set out below:

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Alan Dunsmore

2

Reason for the notification

a)

Position/status

CEO

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Severfield plc

b)

LEI

21380025AWPR781CY104

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 2.5p

 

GB00B27YGJ97

 

b)

Nature of the transaction

Grant of an award under the Company's Deferred Bonus Share Plan. The award is a nil exercise cost option normally exercisable between 3 and 10 years after grant subject to continued employment. No consideration was paid for the grant of the award

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 Nil

211,416

d)

Aggregated information

-

Aggregated volume

-

Price

Not applicable-single transaction

e)

Date of the transaction

2023-07-28

 

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ian Cochrane

2

Reason for the notification

a)

Position/status

COO

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Severfield plc

b)

LEI

21380025AWPR781CY104

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 2.5p

 

GB00B27YGJ97

 

b)

Nature of the transaction

Grant of an award under the Company's Deferred Bonus Share Plan. The award is a nil exercise cost option normally exercisable between 3 and 10 years after grant subject to continued employment. No consideration was paid for the grant of the award.  

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 Nil

188,253

d)

Aggregated information

-

Aggregated volume

-

Price

Not applicable-single transaction

e)

Date of the transaction

2023-07-28

 

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Adam Semple

2

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Severfield plc

b)

LEI

21380025AWPR781CY104

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 2.5p

 

GB00B27YGJ97

 

b)

Nature of the transaction

Grant of an award under the Company's Deferred Bonus Share Plan. The award is a nil exercise cost option normally exercisable between 3 and 10 years after grant subject to continued employment. No consideration was paid for the grant of the award

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 Nil

144,484

d)

Aggregated information

-

Aggregated volume

-

Price

Not applicable-single transaction

e)

Date of the transaction

2023-07-28

 

f)

Place of the transaction

Outside a trading venue

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Derek Randall

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Severfield plc

b)

LEI

21380025AWPR781CY104

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 2.5p

 

GB00B27YGJ97

 

b)

Nature of the transaction

Grant of an award under the Company's Deferred Bonus Share Plan. The award is a nil exercise cost option exercisable normally exercisable between 3 and 10 years after grant subject to continued employment. No consideration was paid for the grant of the award.  

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 Nil

156,893

d)

Aggregated information

-

Aggregated volume

-

Price

Not applicable-single transaction

e)

Date of the transaction

2023-07-28

 

f)

Place of the transaction

Outside a trading venue

 

 

Name of Company Official responsible for making notification: 

Mark Sanderson, Company Secretary

Contact details: 01845 577896

Severfield plc

Severs House

Dalton Airfield Industrial Estate

Thirsk

North Yorkshire

YO7 3JN

28th July 2023

Classification 3.1

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHRBMJTMTAJBFJ
Date   Source Headline
13th Sep 20124:35 pmRNSPrice Monitoring Extension
3rd Sep 20124:40 pmRNSSecond Price Monitoring Extn
3rd Sep 20124:35 pmRNSPrice Monitoring Extension
21st Aug 201211:15 amRNSDividend Payment Date
21st Aug 20127:00 amRNSHalf Yearly Report
9th Aug 20128:45 amRNSHolding(s) in Company
13th Jul 20124:35 pmRNSPrice Monitoring Extension
28th Jun 20124:14 pmRNSHolding(s) in Company
28th Jun 20124:00 pmRNSHolding(s) in Company
19th Jun 201212:00 pmRNSHolding(s) in Company
18th Jun 20129:55 amRNSHolding(s) in Company
13th Jun 20125:45 pmRNSResult of AGM
12th Jun 20123:40 pmRNSDirector/PDMR Shareholding
12th Jun 201211:00 amRNSHolding(s) in Company
11th Jun 20127:00 amRNSTrading Update
18th May 20127:00 amRNSInterim Management Statement
30th Apr 20123:40 pmRNSAnnual Report and Notice of 2012 AGM
20th Mar 20127:00 amRNSFinal Results
14th Feb 201210:30 amRNSHolding(s) in Company
14th Feb 201210:30 amRNSHolding(s) in Company
10th Feb 201211:15 amRNSPreliminary Results Date
21st Dec 201111:50 amRNSDirector/PDMR Shareholding
30th Nov 20114:35 pmRNSPrice Monitoring Extension
16th Nov 20117:00 amRNSInterim Management Statement
18th Oct 20114:55 pmRNSHolding(s) in Company
13th Oct 20117:00 amRNSDirectorate Change
5th Oct 20114:28 pmRNSHolding(s) in Company
5th Oct 20114:25 pmRNSDirector/PDMR Shareholding
5th Oct 20114:22 pmRNSHolding(s) in Company
14th Sep 20115:50 pmRNSHolding(s) in Company
25th Aug 201110:00 amRNSHolding(s) in Company
23rd Aug 20117:00 amRNSDirectorate Change
23rd Aug 20117:00 amRNSHalf Yearly Report
16th Aug 20119:10 amRNSHolding(s) in Company
2nd Aug 201112:45 pmRNSNotice of Results
1st Jul 201112:40 pmRNSDirector/PDMR Shareholding
22nd Jun 20119:00 amRNSInvestor Site Visit
8th Jun 20114:20 pmRNSResult of AGM
8th Jun 20117:00 amRNSAGM Statement
27th May 20119:40 amRNSAnnual Information Update
18th May 20117:00 amRNSInterim Management Statement
4th May 20113:42 pmRNSDirector/PDMR Shareholding
28th Apr 201111:45 amRNSAnnual Report and Notice of Annual General Meeting
15th Apr 20119:58 amRNSHolding(s) in Company
15th Apr 20119:54 amRNSHolding(s) in Company
22nd Mar 20117:00 amRNSFinal Results
27th Jan 20117:00 amRNSCompany Statement & Trading Update
18th Jan 201111:45 amRNSHolding(s) in Company
17th Nov 20107:00 amRNSIMS & Indian JV Opening Ceremony
5th Nov 201010:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.